AZRX
Price:
$3.45
Market Cap:
$3.43M
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company is headquartered in Brooklyn, New York and currently employs 12 full-time employees. The firm is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The firm's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101. MS1819 is an acid-resistant secreted lipase produced by Yarrowia lipolytica, known as LIP2, that the Company is developing through recombinant deoxyribonucleic acid (DNA) technology for the treatment of exocrine...[Read more]
Industry
Biotechnology
IPO Date
2016-10-11
Stock Exchange
NASDAQ
Ticker
AZRX
According to AzurRx BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.84. This represents a change of -13.41% compared to the average of -2.13 of the last 4 quarters.
The mean historical PE Ratio of AzurRx BioPharma, Inc. over the last ten years is -2.85. The current -1.84 PE Ratio has changed 6.37% with respect to the historical average. Over the past ten years (40 quarters), AZRX's PE Ratio was at its highest in in the December 2024 quarter at 0.09. The PE Ratio was at its lowest in in the September 2020 quarter at -937.15.
Average
-2.85
Median
-1.64
Minimum
-8.09
Maximum
-0.66
Discovering the peaks and valleys of AzurRx BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.32%
Maximum Annual PE Ratio = -0.66
Minimum Annual Increase = -60.84%
Minimum Annual PE Ratio = -8.09
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.66 | -60.07% |
| 2020 | -1.64 | 6.94% |
| 2019 | -1.54 | 11.32% |
| 2018 | -1.38 | -60.38% |
| 2017 | -3.48 | 9.98% |
| 2016 | -3.17 | -60.84% |
The current PE Ratio of AzurRx BioPharma, Inc. (AZRX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.28
5-year avg
-1.74
10-year avg
-2.85
AzurRx BioPharma, Inc.’s PE Ratio is less than Lisata Therapeutics, Inc. (-0.97), less than Onconetix, Inc. (-0.08), less than Unity Biotechnology, Inc. (-0.12), less than Atreca, Inc. (-0.04), less than Idera Pharmaceuticals, Inc. (-0.06), greater than VivoSim Labs, Inc. (-2.94), less than RVL Pharmaceuticals plc (-0.05), less than Gritstone bio, Inc. (-0.03), less than Altamira Therapeutics Ltd. (-0.02), less than Q32 Bio Inc. (-0.99),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.97 | $17.86M | |
| -0.08 | $1.67M | |
| -0.12 | $3.44M | |
| -0.04 | $3.57M | |
| -0.06 | $0 | |
| -2.94 | $6.08M | |
| -0.05 | $3.14M | |
| -0.03 | $3.80M | |
| -0.02 | $1.13M | |
| -0.99 | $41.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AzurRx BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AzurRx BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AzurRx BioPharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for AzurRx BioPharma, Inc. (AZRX)?
What is the highest PE Ratio for AzurRx BioPharma, Inc. (AZRX)?
What is the 3-year average PE Ratio for AzurRx BioPharma, Inc. (AZRX)?
What is the 5-year average PE Ratio for AzurRx BioPharma, Inc. (AZRX)?
How does the current PE Ratio for AzurRx BioPharma, Inc. (AZRX) compare to its historical average?